Findings from a qualitative study suggested a greater need for rheumatology clinicians to initiate discussions with patients about neuropsychiatric symptoms.
Brain inflammation appears to influence the mood problems of Alzheimer's patients, rather than traditional markers of the disease like amyloid beta or tau proteins, researchers report.
The findings strengthen evidence on the role inflammation plays in the progression of the disease and offers new pathways to develop therapies for neurological symptoms.